Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Nature Medicine – An exploratory analysis of the 1-year clinical trial PASADENA in individuals with early-stage Parkinson’s disease suggests that prasinezumab might reduce motor signs…